Home > News > NanoCure Changes Name to Avidimer Therapeutics
May 17th, 2005
NanoCure Changes Name to Avidimer Therapeutics
Abstract:
James R. Baker, Jr., M.D., Avidimer's chairman and chief scientific officer, commented, "The name Avidimer Therapeutics refers to our focus on cell-specific targeting of therapeutics and diagnostics through the use of novel branch-like polymers known as dendrimers, which avidly target diseased cells and have the potential to diagnose and treat cancer and other diseases more effectively and completely than current diagnostics and therapeutics. Their small size (less than 5nm) enables them to escape the blood stream through vascular pores, selectively target and treat tumor cells, and be cleared rapidly through the kidney. Preclinical studies have demonstrated the impressive ability of dendrimers to target diseased cells in the body."
Source:
genengnews.com
Bookmark:
| Related News Press |
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||